BFRA - Biofrontera AG

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
Currency in EUR. All numbers in thousands
Revenue12/31/201812/31/201712/31/201612/31/2015
Total Revenue21,10712,0256,1304,138
Cost of Revenue4,4511,7151,6521,236
Gross Profit16,65610,3104,4782,902
Operating Expenses
Research Development4,4274,2254,6406,204
Selling General and Administrative30,70720,01911,6176,929
Non Recurring----
Others----
Total Operating Expenses39,58525,95917,90914,369
Operating Income or Loss-18,478-13,934-11,779-10,231
Income from Continuing Operations
Total Other Income/Expenses Net-791-2,1681,200-972
Earnings Before Interest and Taxes-18,478-13,934-11,779-10,231
Interest Expense-1,784-1,133-1,207-1,168
Income Before Tax-19,269-16,102-10,579-11,203
Income Tax Expense-10,391---
Minority Interest----
Net Income From Continuing Ops-8,878-16,102-10,579-11,203
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-8,878-16,102-10,579-11,203
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-8,878-16,102-10,579-11,203